Catalyst Clinical Research Sold to NovaQuest Capital Management
Catalyst Clinical Research is a niche contract research organization (CRO) that specializes in providing highly tailored clinical operations solutions to the global biopharmaceutical and medical device industries. Catalyst enables clinical trial sponsors to rapidly and cost‐effectively access therapeutically aligned teams and individual resources on an as needed basis as an alternative or adjunct to traditional CRO services. The company’s professionals cover all clinical operations functions, including clinical trial monitoring, project management, study startup/regulatory, quality assurance, and medical writing. Catalyst’s clinical study experience spans all major therapeutic areas and phases (I-IV) of the drug development process. Catalyst is headquartered in the U.S. with operations in Europe.